Status:
COMPLETED
Topical CP-690,550 For Chronic Plaque Psoriasis
Lead Sponsor:
Pfizer
Conditions:
Psoriasis
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Study will test effectiveness of an experimental drug applied once or twice daily to two psoriasis plaques. Requires 1 clinic visit each week for 5 weeks.
Eligibility Criteria
Inclusion
- Having chronic plaque psoriasis for at least 6 months
- Able to withdraw all prior psoriasis treatments
- Must agree to avoid prolonged exposure to the sun and avoid use of tanning booths or other ultraviolet light sources during the study
Exclusion
- Evidence of active, latent, or inadequately treated infection with Mycobacterium tuberculosis
- Pregnant or lactating women
- Unwilling to use appropriate contraceptive methods
Key Trial Info
Start Date :
October 13 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 24 2009
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT00678561
Start Date
October 13 2008
End Date
July 24 2009
Last Update
December 31 2020
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Irvine
Irvine, California, United States, 92697
2
Therapeutics Clinical Research
San Diego, California, United States, 92123
3
RUSH University Medical Center
Chicago, Illinois, United States, 60612
4
Tufts Medical Center
Boston, Massachusetts, United States, 02111